Go to Page # Page of 21
loading

Therapeutic Strategies to Treat Patients with CNS Diseases

 Toshihide Yamashita
  24th-Apr-2019
Description: RGMa is the potent axon growth inhibitor in the CNS. Multiple sclerosis is a demyelinating disorder of the CNS, causing patches of sclerosis in the brain and spinal cord.
Views: 2611
Domain: Medical
Category: Therapy
Contents:
Development of the therapeutic strategies to
treat patients with the CNS diseases

Toshihide Yamashita
Department of Molecular Neuroscience,
Department of Neuro-Medical Science,
Graduate School of Medicine, Osaka University

Why is recovery of the injured CNS so difficult?
How does the CNS recover after injury?
No effective therapy
Spinal cord injury

Stroke

Axonal injury
CNS, central nervous sy ... See more

Recent Presentations

Yalin Firinci
19 August, 2019

Regulatory Science for R&D Promotion

At present, the nationís policy for Research and Development (R&D) promotion of innovative pharmaceuticals & improvement of environments for the R&D is formulated by Japanese gover

...
18 August, 2019
...
16 August, 2019